Literature DB >> 14571195

Sex differences in nevirapine disposition in HIV-infected patients.

Mario Regazzi1, Paola Villani, Elena Seminari, Giovanni Ravasi, Maria Cusato, Francesca Marubbi, Grazia Meneghetti, Renato Maserati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14571195     DOI： 10.1097/00002030-200311070-00018

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  7 in total

1.  Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.

Authors:  Betty J Dong; Yu Zheng; Michael D Hughes; Adam Frymoyer; Davide Verotta; Patricia Lizak; Frederick Sawe; Judith S Currier; Shahin Lockman; Francesca T Aweeka
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

2.  Evaluation of antiretroviral therapy results in Blantyre, Malawi.

Authors:  J J van Oosterhout; N Bodasing; J J Kumwenda; C Nyirenda; J Mallewa; P R Cleary; M P de Baar; R Schuurman; D M Burger; E E Zijlstra
Journal:  Malawi Med J       Date:  2005-12       Impact factor: 0.875

3.  Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.

Authors:  Monica Gandhi; Leslie Z Benet; Peter Bacchetti; Ann Kalinowski; Kathryn Anastos; Alan R Wolfe; Mary Young; Mardge Cohen; Howard Minkoff; Stephen J Gange; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

4.  Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors.

Authors:  Shaheena Asad; Todd Hulgan; Stephen P Raffanti; Jim Daugherty; Wayne Ray; Timothy R Sterling
Journal:  J Natl Med Assoc       Date:  2008-12       Impact factor: 1.798

Review 5.  Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.

Authors:  Iris Usach; Virginia Melis; José-Esteban Peris
Journal:  J Int AIDS Soc       Date:  2013-09-04       Impact factor: 5.396

6.  Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study.

Authors:  Mona Rafik Loutfy; Sharon Lynn Walmsley; Marina Barbara Klein; Janet Raboud; Alice Lin-In Tseng; Sandra Lauren Blitz; Neora Pick; Brian Conway; Jonathan Benjamin Angel; Anita Rochelle Rachlis; Kevin Gough; Jeff Cohen; David Haase; David Burdge; Fiona Mary Smaill; Alexandra de Pokomandy; Hugues Loemba; Sylvie Trottier; Charles Jean la Porte
Journal:  BMC Infect Dis       Date:  2013-06-03       Impact factor: 3.090

Review 7.  Caring for women living with HIV: gaps in the evidence.

Authors:  Mona R Loutfy; Lorraine Sherr; Ulrike Sonnenberg-Schwan; Sharon L Walmsley; Margaret Johnson; Antonella d'Arminio Monforte
Journal:  J Int AIDS Soc       Date:  2013-10-01       Impact factor: 5.396
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.